Gri Bio Inc (GRI)

Apr 02, 2025

GRI Stock Down on Public Offering Despite Encouraging IPF Study Data - MSN

Apr 02, 2025

Apr 02, 2025

Gri Bio Announces Closing Of $5.0 Million Public Offering - MarketScreener

Apr 02, 2025

Apr 02, 2025

GRI Bio Announces Closing of $5.0 Million Public Offering - GlobeNewswire

Apr 02, 2025

Apr 02, 2025

GRI Bio Raises $5M, Eyes $18.3M Total Potential for Breakthrough Autoimmune Treatment - Stock Titan

Apr 02, 2025

Apr 02, 2025

GRI Bio Shares Rebound In After-Hours Trading - Stocks Telegraph

Apr 02, 2025

Apr 01, 2025

GRI Bio (GRI) Reports Positive Interim Safety Results for IPF Tr - GuruFocus

Apr 01, 2025

Apr 01, 2025

Street can a-GRI on phase IIb safety win in IPF with tazarotene - BioWorld MedTech

Apr 01, 2025

Apr 01, 2025

GRI Bio Announces $5 Million Public Offering Amid Market Decline - Nasdaq

Apr 01, 2025

Apr 01, 2025

GRI Bio Prices up to $13 Million Equity Offering - MarketScreener

Apr 01, 2025

Apr 01, 2025

GRI Bio announces $5 million public offering - Investing.com India

Apr 01, 2025

Apr 01, 2025

GRI Bio announces $5 million public offering By Investing.com - Investing.com Australia

Apr 01, 2025

Apr 01, 2025

GRI Bio Announces Pricing of $5.0 Million Public Offering - GlobeNewswire

Apr 01, 2025

Apr 01, 2025

GRI Bio Secures $5M Funding Deal: Warrants Could Add $13.3M More - Stock Titan

Apr 01, 2025

Apr 01, 2025

Why Is Nano Cap GRI Bio Stock Skyrocketing On Tuesday?GRI Bio (NASDAQ:GRI) - Benzinga

Apr 01, 2025

Apr 01, 2025

GRI Bio’s IPF drug shows promise in early trial By Investing.com - Investing.com South Africa

Apr 01, 2025

Apr 01, 2025

GRI Bio reports interim 2-week safety results from Phase 2a study of GRI-0621 - TipRanks

Apr 01, 2025

Apr 01, 2025

GRI Bio’s IPF drug shows promise in early trial - Investing.com

Apr 01, 2025

Apr 01, 2025

Gri Bio IncIDMC Recommends Continuation Of Study With No Safety Concerns - MarketScreener

Apr 01, 2025

Apr 01, 2025

GRI Bio Reports Encouraging Interim 2-Week Safety Results - GlobeNewswire

Apr 01, 2025

Apr 01, 2025

Clinical Trial Breakthrough: GRI-0621 Clears Key Safety Milestone for IPF Treatment - Stock Titan

Apr 01, 2025

Mar 31, 2025

GRI Bio secures global patents for NKT cell modulators By Investing.com - Investing.com South Africa

Mar 31, 2025

Mar 31, 2025

GRI Bio secures global patents for NKT cell modulators - Investing.com

Mar 31, 2025

Mar 31, 2025

GRI Bio announces the granting of two global patents for Europe, Japan - TipRanks

Mar 31, 2025

Mar 31, 2025

GRI Bio Bolsters Intellectual Property Portfolio with Granting of Two Global Patents for Europe and Japan - GlobeNewswire

Mar 31, 2025

Mar 31, 2025

Global Patent Victory: GRI Bio's Breakthrough NKT Cell Treatment for Autoimmune Disease Gets Dual Approval - Stock Titan

Mar 31, 2025

Mar 28, 2025

Vallon Pharmaceuticals stock plunges to 52-week low of $4.95 By Investing.com - Investing.com South Africa

Mar 28, 2025

Mar 28, 2025

Vallon Pharmaceuticals stock plunges to 52-week low of $4.95 - Investing.com India

Mar 28, 2025

Mar 28, 2025

Pre-market Movers: PSTX, HOOK, MDAI, ALEC... - RTTNews

Mar 28, 2025

Mar 20, 2025

GRI Bio (GRI) to Release Quarterly Earnings on Thursday - Defense World

Mar 20, 2025

Mar 18, 2025

GRI Bio Participates in a Virtual Investor CEO Connect Segment - GlobeNewswire

Mar 18, 2025

Mar 18, 2025

GRI Bio's Breakthrough IPF Drug Shows Promise, Key Data Coming Next Quarter - StockTitan

Mar 18, 2025

Mar 17, 2025

GRI Bio expects cash to fund operations into Q2 of 2025 - TipRanks

Mar 17, 2025

Mar 17, 2025

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Mar 17, 2025

Mar 17, 2025

GRI stock touches 52-week low at $5.12 amid market fluctuations - Investing.com

Mar 17, 2025

Mar 17, 2025

GRI Bio, Inc. Anticipates Key Phase 2a Data Readouts for GRI-0621 in 2025 While Securing Cash Runway for Operations - Nasdaq

Mar 17, 2025

Mar 17, 2025

GRI Bio Reports Full Year 2024 Financial Results and - GlobeNewswire

Mar 17, 2025

Mar 17, 2025

GRI Bio's IPF Treatment Shows Promise: Key Clinical Data Coming in 2025 - StockTitan

Mar 17, 2025

Mar 14, 2025

GRI Bio, Inc. SEC 10-K Report - TradingView

Mar 14, 2025

Mar 11, 2025

GRI Bio regains compliance with Nasdaq minimum bid rule By Investing.com - Investing.com Australia

Mar 11, 2025

Mar 11, 2025

GRI Bio Regains Compliance with Nasdaq’s Minimum Bid Price Rule - GlobeNewswire

Mar 11, 2025

Mar 11, 2025

GRI Bio Back In Compliance With Nasdaq Minimum Bid Rule - Nasdaq

Mar 11, 2025

Mar 11, 2025

GRI Bio regains compliance with Nasdaq minimum bid rule - Investing.com India

Mar 11, 2025

Mar 11, 2025

GRI Bio, Inc. Regains Compliance with Nasdaq Minimum Bid Price Rule - Nasdaq

Mar 11, 2025

Mar 11, 2025

2 ETFs That Are Surging While U.S. Stocks Are Slumping - The Globe and Mail

Mar 11, 2025

Mar 10, 2025

Meta Stock: The Potential and Pitfalls of Its Reality Labs Bet - The Globe and Mail

Mar 10, 2025

Feb 25, 2025

Stock market today: Wah Fu Education Group +219.55%, Jet.AI +46.26% among top gainers in early trading - Business Upturn

Feb 25, 2025

Feb 21, 2025

GRI Bio announces 1-for-17 reverse stock split to regain Nasdaq compliance - MSN

Feb 21, 2025

Feb 20, 2025

GRI Bio Announces Reverse Stock Split - The Manila Times

Feb 20, 2025

Feb 20, 2025

GRI Bio Stock Set to Reverse Split on Monday, February 24th (NASDAQ:GRI) - Defense World

Feb 20, 2025

Feb 19, 2025

Can GRI Bio's 17:1 Reverse Split Save Its Nasdaq Listing? Key Details Revealed - StockTitan

Feb 19, 2025

Feb 19, 2025

GRI Bio, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference - GlobeNewswire

Feb 19, 2025

Feb 19, 2025

Virtual Investor “Top 5 for ’25” Conference Hosted by JTC Now Available On-Demand - The State

Feb 19, 2025

Feb 19, 2025

Vstock Transfer Announces Sponsorship of the Centri Capital Conference at Nasdaq - The Manila Times

Feb 19, 2025

Feb 19, 2025

GRI Bio, Inc. Highlights Key Investment Reasons at Virtual Investor Conference - Nasdaq

Feb 19, 2025

Feb 19, 2025

Virtual Investor "Top 5 for '25" Conference Hosted by JTC Now Available On-Demand - Big News Network

Feb 19, 2025